Glenmede Trust Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
Similar funds
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.